<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Conventional <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers are unsuitable for detecting <z:mp ids='MP_0002038'>carcinoma</z:mp> at an early stage and lack clinical efficacy and utility </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we attempted to investigate the differences in serum metabolite profiles of <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancers</z:e> and healthy volunteers using a metabolomic approach and searched for sensitive and specific metabolomic biomarker candidates </plain></SENT>
<SENT sid="2" pm="."><plain>Human serum samples were obtained esophageal (n = 15), gastric (n = 11), and colorectal (n = 12) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and healthy volunteers (n = 12) </plain></SENT>
<SENT sid="3" pm="."><plain>A model for evaluating metabolomic biomarker candidates was constructed using multiple classification analysis, and the results were assessed with receiver operating characteristic curves </plain></SENT>
<SENT sid="4" pm="."><plain>Among the 58 metabolites, the levels of nine, five and 12 metabolites were significantly changed in the esophageal, gastric and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, respectively, compared with the healthy volunteers </plain></SENT>
<SENT sid="5" pm="."><plain>Multiple classification analysis revealed that the variations in the levels of <z:chebi fb="0" ids="30794">malonic acid</z:chebi> and <z:chebi fb="0" ids="17115,29999">L-serine</z:chebi> largely contributed to the separation of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>; <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> was characterized by changes in the levels of <z:chebi fb="0" ids="33404">3-hydroxypropionic acid</z:chebi> and <z:chebi fb="2" ids="32816">pyruvic acid</z:chebi>; and <z:chebi fb="0" ids="16977">L-alanine</z:chebi>, glucuronoic <z:chebi fb="0" ids="25000">lactone</z:chebi> and <z:chebi fb="0" ids="18050,30011">L-glutamine</z:chebi> contributed to the separation of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Our approach revealed that some metabolites are more sensitive for detecting <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> than conventional biomarkers </plain></SENT>
<SENT sid="7" pm="."><plain>Our study supports the potential of metabolomics as an early diagnostic tool for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>